Search Results for "Fentanyl Patch Bioavailability"
Original Source: Relative Bioavailability of a Fentanyl Patch
Tohe purpose of this study is to demonstrate the bioequivalence of a fentanyl patch transdermal delivery system.
Matching Channels
Selective monoamine oxidase type B MAOB inhibitors
The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...
The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...
Matching News
Janssen Files Additional Indication For OneDuro Patch In Chronic Pain
Janssen Pharmaceuticals has applied for an additional indication of OneDuro Patch (fentanyl), a drug used for pain during cancer treatment, for the treatment of “moderate to severe chronic pain,”...
Fentanyl Injection Shortages Reported: Severe Adverse Events as AttorneyOne Informs
San Diego, CA (PRWEB) December 21, 2012 AttorneyOne.com, a recognized authority on law, informs on the latest news concerning Fentanyl: As updated on November 27th, 2012 by the American Society of...
Life-Threatening Coma in a Patient on Transdermal Fentanyl
A fentanyl patch used to alleviate chronic back pain nearly proved fatal when this elderly woman fell asleep in the sun. Journal of Medical Case Reports
Fentanyl Patch: New Wrongful Death Claim
According to court documents, on June 19th, 2012, Tracy King filed a wrongful death claim at Philadelphia’s Common Pleas Court (case no. 120602334) alleging that her sister’s death was caused by...
Watson Fentanyl Pain Patch Lawsuits MDL Announced
As filed on August 7th 2012, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has decided to centralize all wrongful death lawsuits involving Watson Fentanyl pain patches into the Northern D...
FDA announces New Safety Measures for Duragesic (Transdermal Fentanyl)
On July 9th, 2012 the US FDA announced new safety measures for a class of opioid medications, including Duragesic (transdermal Fentanyl). Opioids, when prescribed by physicians to patients who should...
More than 53,000 Duragesic (Fentanyl) Patches Recalled by J&J
The US FDA announced on its June 6th, 2012 enforcement report that J&J recalled more than 53,000 Duragesic (Fentanyl Transdermal System) patches because of crystallization. Fentanyl (brand names D...
San Diego, CA (PRWEB) February 15, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion in view of the recent news on...
Matching PubMed Articles
Abstract Context: Intranasal fentanyl spray (INFS) was developed for the treatment of breakthrough pain in cancer patients using an alternative route of administration. Objective: The aim of this clin...
PURPOSE: Opioids are used in controlling several types of pain. This study was designed to evaluate the efficacy and safety of the fentanyl transdermal patch-type system (Durogesic(R) D-TRANS). METHOD...
Bellei, E., Roncada, P., Pisoni, L., Joechler, M., Zaghini, A. The use of fentanyl-patch in dogs undergoing spinal surgery: plasma concentrations and analgesic efficacy. J. vet. Pharmacol. Therap. doi...
Pharmacokinetics of Non-Intravenous Formulations of Fentanyl.
Fentanyl was structurally designed by Paul Janssen in the early 1960s as a potent opioid analgesic (100-fold more potent than morphine). It is a full agonist at μ-opioid receptors and possesses physi...
Purpose: This study was carried out to compare fentanyl 0.5 µg kg(-1)-propofol as opposed to fentanyl 1 µg kg(-1)-propofol in terms of providing adequate analgesia, and a comparable recovery profile...
